Meeting details menu

Meeting Authors
Meeting Abstracts
Keynote lectures
Oral communications
Poster presentations
Special symposia
Other

Acta Physiologica Congress

Back

Acta Physiologica 2011; Volume 203, Supplement 686
Joint Congress of FEPS and Turkish Society of Physiological Sciences
9/3/2011-9/7/2011
Istanbul, Turkey


THE EFFECT OF LOW-LEVEL LASER THERAPY IN PATIENTS WITH NERVE IMPAIRMENT FOLLOWING THE TREATMENT OF BISPHOSPHONATE - A CASE REPORT
Abstract number: PC161

Koray1 Meltem, Esra2 Somtürk, Ilknur2 Özcan, Hakki1 Tanyeri

1Istanbul University, Faculty of Dentistry, Department of Oral Surgery and Oral Medicine
2Istanbul University, Faculty of Dentistry, Department of Oral and Maxillofacial Radiology

Objective: 

Osteonecrosis of the jaw (ONJ) is a major complication associated with long-term use of bisphosphonates. Clinical signs and symptoms commonly reported include pain, swelling, the presence of pus, loose teeth, ill-fitting dentures, and paresthesias of the inferior alveolar nerve when affects the mandible. Low-level laser therapy (LLLT) with diode laser has been reported for biostimulation in the treatment of paresthesia. This paper reports the effects of LLLT in patients with nerve impairment following after therapy of bisphosphonates.

Methods: 

We presented LLLT with diode laser to a 65-year-old woman with ONJ, who was treated with zoledronic acid for multiple bone metastasis after she had been diagnosed as multiple myeloma 7 years ago. Her complaints were paresthesia in her right lower lip. According to the intraoral and radiographic examinations and symptoms of the patient, ONJ was described as Stage 0 which includes patients exposed to bisphosphonate and who is present with non-specific symptoms or without clinical and radiographic abnormalities.

Results: 

In addition to antibiotheraphy LLLT with diode laser was applied two times a week for six months. Parestesia was completely healed. She had no signs or symptoms of ONJ since then.

Conclusions: 

LLLT seemed to be effective in reducing nerve impairment following the treatment of bisphosphonates.

To cite this abstract, please use the following information:
Acta Physiologica 2011; Volume 203, Supplement 686 :PC161

Our site uses cookies to improve your experience.You can find out more about our use of cookies in our standard cookie policy, including instructions on how to reject and delete cookies if you wish to do so.

By continuing to browse this site you agree to us using cookies as described in our standard cookie policy .

CLOSE